Ipamorelin

Ipamorelin is a synthetic pentapeptide belonging to the Growth Hormone Releasing Peptide (GHRP) family. It is designed to stimulate natural growth hormone (GH) release by activating ghrelin receptors in the pituitary gland.

Compared with earlier GHRPs, Ipamorelin is more selective and has minimal effect on cortisol or prolactin levels in research models.

Ipamorelin is widely studied in laboratory research on endocrine signaling, metabolism, and growth hormone physiology.

It is not an approved therapeutic drug.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

This product is currently out of stock and unavailable.

SKU: N/A Category:

๐Ÿงฌ What Ipamorelin Is

Ipamorelin is a synthetic pentapeptide belonging to the Growth Hormone Releasing Peptide (GHRP) family. It is designed to stimulate natural growth hormone (GH) release by activating ghrelin receptors in the pituitary gland.

Compared with earlier GHRPs, Ipamorelin is more selective and has minimal effect on cortisol or prolactin levels in research models.

Ipamorelin is widely studied in laboratory research on endocrine signaling, metabolism, and growth hormone physiology.

It is not an approved therapeutic drug.


โš™๏ธ Mechanism of Action

Ipamorelin works through ghrelin receptor activation and downstream GH signaling.


๐Ÿ”น Ghrelin Receptor Activation

Ipamorelin binds to the Growth Hormone Secretagogue Receptor (GHS-R1a) in the hypothalamus and pituitary.

This leads to:

  • Increased GH secretion

  • Increased GH pulse amplitude

  • Enhanced endogenous hormone release

This pathway works independently of GHRH signaling.


๐Ÿ”น Selective Hormonal Profile

Unlike many GHRPs, Ipamorelin has minimal stimulation of:

  • Cortisol

  • Prolactin

This makes it useful in research on targeted GH signaling.


๐Ÿ”น Synergy With GHRH Analogs

When combined with GHRH analogs (like CJC-1295 w/o DAC), Ipamorelin produces greater GH release than either alone.

This synergy is widely studied in endocrine physiology research.


๐Ÿ”น Downstream IGF-1 Effects

Increased GH stimulates liver production of IGF-1, affecting:

  • Protein synthesis signaling

  • Tissue growth pathways

  • Fat metabolism

These downstream effects are studied in metabolic and endocrine research.


๐Ÿ“Š Research Evidence & Experimental Findings

Ipamorelin has been studied in animal models and limited human research.


๐Ÿ“Œ Growth Hormone Studies

Research shows Ipamorelin increases GH secretion and pulse amplitude.

It has been used in diagnostic and endocrine physiology studies.


๐Ÿ“Œ Endocrine Research

Ipamorelin is used to study:

  • Pituitary hormone regulation

  • Aging-related GH decline

  • Interaction between ghrelin and GHRH signaling


๐Ÿ“Œ Body Composition & Metabolic Research

GH secretagogues are studied in models examining:

  • Fat metabolism

  • Lean mass signaling

  • Tissue repair pathways

Large clinical outcome trials specific to Ipamorelin are limited.


๐Ÿงช Safety & Side Effects

Long-term human safety data are limited.


โš ๏ธ Possible Effects

Reported in research settings:

  • Injection site irritation

  • Headache

  • Flushing

  • Mild nausea

These are generally mild.


โš ๏ธ Hormonal-Related Risks

Because GH and IGF-1 may increase:

  • Water retention

  • Joint discomfort

  • Insulin sensitivity changes

These risks depend on dose and duration.


โš ๏ธ Unknowns

  • Long-term endocrine effects

  • Optimal dosing patterns

  • Effects in different populations

More research is needed.


โš–๏ธ Regulatory Status

  • Not FDA-approved as a therapeutic drug.

  • Used in research settings.

  • Banned by the World Anti-Doping Agency (WADA).

It is not approved for general medical use.


๐Ÿ”š Bottom Line

  • Ipamorelin is a selective GHRP that stimulates natural growth hormone release through ghrelin receptor activation.

  • It has minimal effect on cortisol or prolactin compared with earlier GHRPs.

  • Evidence comes from endocrine research and limited human studies.

  • It is not approved for medical use and remains a research-stage compound.

Strength

5mg, 10mg, 5mg Kit (10 Vials), 10mg Kit (10 Vials)

Reviews

There are no reviews yet.

Be the first to review “Ipamorelin”

Your email address will not be published. Required fields are marked *